-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology In Vitro Test Platform: Features and Advantages Analysis
Author:
InnoModels
Release time:
2024-07-03
With the deepening of biomedical research and the rapid development of technology, in vitro testing platforms have become an indispensable tool in scientific research and clinical work. With its advanced technology and rich experience, InnoModels Biotechnology has successfully developed an efficient and accurate in vitro test platform, which provides a brand new solution for biomedical research and clinical diagnosis. In this article, we will introduce the features and advantages of InnoModels' in vitro testing platform in detail.
Technical features:
1. High sensitivity and specificity: InnoModels' in vitro bioassay platform adopts advanced biomarker detection technologies, such as Luminex multiplexing technology, which is capable of realizing accurate and multiplexed detection of a variety of cytokines and biomarkers. With high sensitivity and specificity, this technology can accurately identify and measure the content of target biomolecules, providing researchers with reliable data support.
2. Cell-based technology: In addition to traditional biomarker detection, InnoModels uses cell-based technology for detection. By co-culturing the samples to be detected with specific cell models that mimic the environment within the organism, rapid and accurate identification of microorganisms (e.g., bacteria, viruses, and fungi) is achieved. This technique not only improves the sensitivity of the test, but also increases the accuracy of the test.
3. Fast and Convenient: The operation of the InnoModels Biotechnology in vitro platform is simple and does not require complex equipment or technical support. Users only need to add the samples to be tested into specific petri dishes and incubate them on the detection platform, and then use special fluorescent dyes for labeling and detection. The whole process is fast and convenient, and results are usually available in just a few hours, greatly improving work efficiency.

Advantage analysis:
1. Efficiency: The in vitro assay platform of InnoModels is capable of detecting multiple cytokines and biomarkers at the same time, which greatly improves the experimental efficiency. In addition, the platform also supports rapid and convenient microbial detection, which provides strong support for rapid diagnosis and treatment of diseases.
2. Accuracy: The platform adopts advanced biomarker detection technology and cell-based technology to ensure the accuracy and reliability of the test results. Whether it is the detection of cytokines and biomarkers or microorganisms, it can provide accurate data support.
3. Ease of operation: The InnoModels in vitro assay platform is easy to operate and requires no special skills or equipment. Users only need to follow the instructions to easily complete the testing process, reducing the threshold and cost of use.
4. Widely used: The platform is suitable for biomedical research, clinical diagnosis, environmental protection, food safety and other fields. Whether it is the study of disease pathogenesis, drug screening and evaluation, or environmental monitoring and food safety testing, it can be widely applied.
Conclusion:
With its efficient, accurate, fast and convenient technical features and wide application value, the in vitro assay platform of InnoModels Biotechnology provides a brand new solution for biomedical research and clinical diagnosis. The platform not only improves experimental efficiency and data reliability, but also lowers the threshold and cost of use, providing strong support for researchers and clinicians. It is believed that in the future, InnoModels' in vitro testing platform will be applied in more fields, bringing more convenience and safety protection to people's health and life.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd